{"id":774627,"date":"2023-08-02T12:43:05","date_gmt":"2023-08-02T16:43:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/"},"modified":"2023-08-02T12:43:05","modified_gmt":"2023-08-02T16:43:05","slug":"pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/","title":{"rendered":"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">PRINCETON, N.J., Aug.  02, 2023  (GLOBE NEWSWIRE) &#8212; PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company\u2019s proprietary T cell activating platforms, today announced that Dr. Frank Bedu-Addo, Chief Executive Officer, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference 2023 being held August 7-8, 2023. Details for the event are as follows:<\/p>\n<p align=\"justify\">\n        <strong>BTIG Virtual Biotechnology Conference 2023<\/strong><br \/>\n        <br \/>Presentation Date: Tuesday, August 8, 2023<br \/>Event: Fireside chat <br \/>Time: 11:30 AM EDT<\/p>\n<p align=\"justify\">For more information about the conference or to schedule one-on-one meetings, please contact your BTIG representative directly.<\/p>\n<p align=\"justify\">\n        <strong>About PDS Biotechnology<\/strong><br \/>\n        <br \/>PDS Biotech is a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer and infectious disease immunotherapies based on our proprietary Versamune<sup>\u00ae<\/sup>, Versamune<sup>\u00ae<\/sup> plus PDS0301, and Infectimune<sup>\u00ae<\/sup> T cell-activating platforms. We believe our targeted immunotherapies have the potential to overcome the limitations of current immunotherapy approaches through the activation of the right type, quantity and potency of T cells. To date, our lead Versamune<sup>\u00ae<\/sup> clinical candidate, PDS0101, has demonstrated the ability to reduce and shrink tumors and stabilize disease in combination with approved and investigational therapeutics in patients with a broad range of HPV16-associated cancers in multiple Phase 2 clinical trials and will be advancing into a Phase 3 clinical trial in combination with KEYTRUDA<sup>\u00ae<\/sup> for the treatment of recurrent\/metastatic HPV16-positive head and neck cancer in 2023. Our Infectimune<sup>\u00ae<\/sup> based vaccines have also demonstrated the potential to induce not only robust and durable neutralizing antibody responses, but also powerful T cell responses, including long-lasting memory T cell responses in pre-clinical studies to date. To learn more, please visit www.pdsbiotech.com or follow us on Twitter at @PDSBiotech.<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations:<\/strong><br \/>\n        <br \/>Deanne Randolph<br \/>PDS Biotech<br \/>Phone: +1 (908) 517-3613<br \/>Email: drandolph@pdsbiotech.com<\/p>\n<p align=\"justify\">Rich Cockrell<br \/>CG Capital<br \/>Phone: +1 (404) 736-3838<br \/>Email: pdsb@cg.capital<\/p>\n<p align=\"justify\">\n        <strong>Media Contacts:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Gv0bKieUUk-A_GAzr9nZ4aDFpfVr3c2ftt3gyjN-PbkR9AMvMqNuU8ShB7BABstT12eIr2vGI6ql3twQ11Kn7l_7REdbnLLD--X_ZHXKoyZbgdimjb00i70dxz9L1x51aBvF5fOsEM9t-SGM2oPZryI6XcMcMDCI7EfbI64pytc3BWxosrUpSbQLygYyBaHRntebdMmGIg9GZXtEtsLbr3d3mXzREy-zrDgdiuCqSMpPlxVA_5heDFgiqIZWeJqj8BMfVggxM1cD6d5LCB_pJg==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <u>Tiberend Strategic Advisors, Inc.<\/u><br \/>\n        <\/a><br \/>\n        <br \/>Dave Schemelia<br \/>Phone: +1 (609) 468-9325<br \/>dschemelia@tiberend.com<\/p>\n<p align=\"justify\">Eric Reiss<br \/>Phone: +1 (802) 249-1136<br \/>ereiss@tiberend.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjBkMjkzYTUtMTA2Mi00NGU3LTkwMDEtZTQwZjdmZjFiN2JiLTEwMjg3NjE=\/tiny\/PDS-Biotechnology-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company\u2019s proprietary T cell activating platforms, today announced that Dr. Frank Bedu-Addo, Chief Executive Officer, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference 2023 being held August 7-8, 2023. Details for the event are as follows: BTIG Virtual Biotechnology Conference 2023 Presentation Date: Tuesday, August 8, 2023Event: Fireside chat Time: 11:30 AM EDT For more information about the conference or to schedule one-on-one meetings, please contact your BTIG representative directly. About PDS Biotechnology PDS Biotech is a clinical-stage immunotherapy company developing a growing pipeline &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-774627","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company\u2019s proprietary T cell activating platforms, today announced that Dr. Frank Bedu-Addo, Chief Executive Officer, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference 2023 being held August 7-8, 2023. Details for the event are as follows: BTIG Virtual Biotechnology Conference 2023 Presentation Date: Tuesday, August 8, 2023Event: Fireside chat Time: 11:30 AM EDT For more information about the conference or to schedule one-on-one meetings, please contact your BTIG representative directly. About PDS Biotechnology PDS Biotech is a clinical-stage immunotherapy company developing a growing pipeline &hellip; Continue reading &quot;PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-02T16:43:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023\",\"datePublished\":\"2023-08-02T16:43:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/\"},\"wordCount\":328,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/\",\"name\":\"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=\",\"datePublished\":\"2023-08-02T16:43:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/","og_locale":"en_US","og_type":"article","og_title":"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023 - Market Newsdesk","og_description":"PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company\u2019s proprietary T cell activating platforms, today announced that Dr. Frank Bedu-Addo, Chief Executive Officer, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference 2023 being held August 7-8, 2023. Details for the event are as follows: BTIG Virtual Biotechnology Conference 2023 Presentation Date: Tuesday, August 8, 2023Event: Fireside chat Time: 11:30 AM EDT For more information about the conference or to schedule one-on-one meetings, please contact your BTIG representative directly. About PDS Biotechnology PDS Biotech is a clinical-stage immunotherapy company developing a growing pipeline &hellip; Continue reading \"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-02T16:43:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023","datePublished":"2023-08-02T16:43:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/"},"wordCount":328,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/","name":"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=","datePublished":"2023-08-02T16:43:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTI2OCM1NzMxNzkwIzIwMTcxODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pds-biotech-to-present-at-btig-virtual-biotechnology-conference-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=774627"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774627\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=774627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=774627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=774627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}